share_log

Ascendiant Capital Initiates Coverage On NRX Pharmaceuticals With Buy Rating, Announces Price Target of $4

Ascendiant Capital Initiates Coverage On NRX Pharmaceuticals With Buy Rating, Announces Price Target of $4

Ascendiant Capital以买入评级开始对NRX Pharmicals进行报道,宣布目标股价为4美元
Benzinga Real-time News ·  2022/11/09 06:22

Ascendiant Capital analyst Edward Woo initiates coverage on NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy rating and announces Price Target of $4.

Ascendiant Capital分析师Edward Woo以买入评级开始对NRX Pharmicals(纳斯达克股票代码:NRXP)进行报道,并宣布目标股价为4美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发